1. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis
   Gennaro Galizia et al, 2015, Surgery CrossRef
2. MicroRNAs in the anticancer effects of celecoxib: A systematic review
   Mohammad Amir Mishan et al, 2020, European Journal of Pharmacology CrossRef
3. Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery
   Eva Lieto et al, 2017, Journal of Gastrointestinal Surgery CrossRef
4. Indomethacin Disrupts Autophagic Flux by Inducing Lysosomal Dysfunction in Gastric Cancer Cells and Increases Their Sensitivity to Cytotoxic Drugs
   Jorge Vallecillo-Hernández et al, 2018, Scientific Reports CrossRef
5. Role of Anti-inflammatory Drugs in the Colorectal Cancer
   Oumer Sada et al, 2020, Hospital Pharmacy CrossRef
6. TNFAIP6 promotes invasion and metastasis of gastric cancer and indicates poor prognosis of patients
   Xiangwen Zhang et al, 2021, Tissue and Cell CrossRef
7. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy
   Nan Wang et al, 2021, Frontiers in Oncology CrossRef
8. Celecoxib in Cancer Therapy and Prevention – Review
   Natalia Tołoczko-Iwaniuk et al, 2019, Current Drug Targets CrossRef
9. MicroRNA‑663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma
   Meirong Wang et al, 2018, Experimental and Therapeutic Medicine CrossRef
10. Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction
    Jianping Xiong et al, 2021, Frontiers in Surgery CrossRef
11. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer
    Wei Zhang, 2015, World Journal of Gastroenterology CrossRef
12. Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer
    Gennaro Galizia et al, 2017, Diseases of the Colon & Rectum CrossRef
13. Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET
    Kyung-Ho Jung et al, 2022, Molecular Imaging CrossRef
14. Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis
    JINGTAO ZHONG et al, 2015, Oncology Reports CrossRef
15. MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21
    Chun Chen et al, 2016, Cancer Medicine CrossRef
16. DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
    Diana Cervantes-Madrid et al, 2017, BMC Cancer CrossRef
17. Hitting the Bull’s-Eye in Metastatic Cancers—NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death
    Stephen Ralph et al, 2015, Pharmaceuticals CrossRef
18. Host knockout of E-prostanoid 2 receptors reduces tumor growth and causes major alterations of gene expression in prostaglandin E2-producing tumors
    Annika Gustafsson Asting et al, 2017, Oncology Letters CrossRef
19. EGFR, but not COX‑2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
    Johan Fagman et al, 2019, Oncology Letters CrossRef